SCHEMBL27899088

SCHEMBL27899088

Nc1nnc(N2C[CH]OCC2)c(-c2ccccc2)n1

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 16/20 0.59
ADORA1 P30542 15/20 0.59
ALDH1A1 P00352 1/20 0.45
CASP1 P29466 1/20 0.45
HSD17B10 Q99714 1/20 0.45
CSNK1A1 P48729 1/20 0.43
CLK4 Q9HAZ1 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
ADORA2B P29275 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2323067 0.85 ADORA2A (0.62) ADORA2AADORA1ALDH1A1CASP1HSD17B10
Ethylamine SCHEMBL27882003 0.79 ADORA1 (0.60) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2323881 0.79 ADORA2A (0.67) ADORA2AADORA1HSD17B10CSNK1A1CLK4
SCHEMBL2321488 0.77 ADORA2A (0.65) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2324852 0.75 ADORA2A (0.63) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL27990333 0.74 ADORA2A (0.66) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2329578 0.74 ADORA2A (1.00) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2327016 0.74 ADORA2A (0.58) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2328626 0.74 ADORA2A (0.80) ADORA2AADORA1ALDH1A1CASP1HSD17B10
SCHEMBL2322912 0.74 ADORA2A (0.62) ADORA2AADORA1ALDH1A1CASP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102822150-A 1,2, 4-triazin-4-amine derivatives HEPTARES THERAPEUTICS LTD 2012-12-12 CN claimed
CN-102822150-A 1,2, 4-triazin-4-amine derivatives HEPTARES THERAPEUTICS LTD 2012-12-12 CN disclosed